SUBSCRIBE
SUBSCRIBE
News   Drug Development

Boehringer Ingelheim Corporation Clot-Buster Drug Didn’t Help Cardiac Arrest Survival

December 18, 2008 | 
1 min read
Dec. 17 (Bloomberg) -- A clot-busting drug made by Boehringer Ingelheim GmbH didn’t improve the survival of patients who were treated away from a hospital after their hearts stopped functioning, a study found.
Clinical research Postmarket research
Boehringer Ingelheim
MORE ON THIS TOPIC
Trend artwork sketch montage 3D collage of young man hold laptop climb up pile coins economy savings cash trade finance career promotion.
Cancer
Kura’s encouraging cancer drug data could unlock $2B market opportunity
May 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Germany can produce biotech winners. Europe must back them better.
May 27, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
Active construction site with cranes, workers, builders and skyscrapers under development. Process of building. Vector illustration. Line art style. Isometric view of a monolithic frame building.
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
May 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Gene editing
Lilly’s Verve gambit pays off as base editor cuts cholesterol in early study
May 26, 2026
 · 
2 min read
 · 
Tristan Manalac